Rahika 150 mg Tablet | Uses, Side Effects, Price

Home
Medicine
Rahika 150 mg Tablet 12's

Rahika 150 mg Tablet 12's, Pack of 12 TabletS

Written By ,

Reviewed By Veda Maddala , M Pharmacy

Rahika 150 mg Tablet is used to treat lung cancer that has spread to nearby tissues or other body parts. It contains Capmatinib, which helps slow or stop the growth of cancer cells. Rahika 150 mg Tablet may cause common side effects such as nausea, vomiting, coughing, difficulty breathing, fatigue, weakness, loss of appetite, muscle or bone pain, swelling in the hands or feet, and changes in certain blood tests. If you have any allergies, are pregnant or breastfeeding, are taking any other medications, or have any existing medical conditions, inform your doctor before using this medication.

Also Explore

Composition :

CAPMATINIB-150MG

Manufacturer/Marketer :

Novartis India Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Rahika 150 mg Tablet

Rahika 150 mg Tablet is used to treat advanced or metastatic non-small cell lung cancer (NSCLC). Lung cancer is a type of cancer that begins when cells in the lungs grow abnormally. These cells do not perform normal lung functions and fail to form healthy lung tissue. In this condition, lung cells grow uncontrollably and, if not identified early, may spread to other body parts (metastatic). NSCLC is a category of lung cancer that happens when cells that form the lining of the lung start growing uncontrollably.

Rahika 150 mg Tablet contains 'Capmatinib,' which belongs to a class of medications called 'kinase inhibitors.' It blocks the action of an abnormal protein (the mesenchymal-epithelial transition [MET] gene) that helps cancer cells in the lungs grow and multiply, thereby preventing cancer from spreading.

Rahika 150 mg Tablet should be taken precisely as prescribed by your doctor. Continue taking Rahika 150 mg Tablet for the duration specified, based on your medical condition. In some cases, Rahika 150 mg Tablet may cause common side effects such as nausea, vomiting, coughing, difficulty breathing, fatigue, weakness, loss of appetite, muscle or bone pain, swelling in the hands or feet, or changes in specific blood tests. These side effects are generally mild and do not need medical attention. However, you are advised to consult your doctor if these side effects persist or worsen.

Before starting treatment with Rahika 150 mg Tablet , inform your doctor if you are allergic to any of its ingredients or other medications. Rahika 150 mg Tablet may increase your sensitivity to sunlight, so limiting exposure to sunlight and using sunscreen and protective clothing outdoors is essential. Do not use Rahika 150 mg Tablet if you are pregnant or planning pregnancy, as it may harm an unborn baby. Inform your doctor of your medical history, particularly if you have liver disease, lung problems, or pancreatitis (inflammation of the pancreas), before starting Rahika 150 mg Tablet .

Uses of Rahika 150 mg Tablet

Rahika 150 mg Tablet is used in the treatment of Advanced or Metastatic Non-small cell lung cancer (NSCLC). The detailed use of Rahika 150 mg Tablet is as follows:<br/>• Treatment of Advanced or Metastatic Non-small cell lung cancer (NSCLC): Rahika 150 mg Tablet treats metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutation by inhibiting the MET gene, slowing cancer cell growth and spread.<br/>

Directions for Use

• Rahika 150 mg Tablet can be taken with or without food.• Take Rahika 150 mg Tablet twice daily at the same time each day for best results, or as advised by your doctor.• Swallow Rahika 150 mg Tablet as a whole with a glass of water.• Do not chew, crush, or break it.

Medicinal Benefits

Rahika 150 mg Tablet is a targeted cancer medicine used to treat advanced or metastatic non-small cell lung cancer or cancer that cannot be surgically removed. This type of cancer is known to spread rapidly to other areas of the body (metastatic). Rahika 150 mg Tablet circulates through the bloodstream and targets cancerous cells in the lungs and other parts of the body. It contains Capmatinib, which belongs to a class of medications called 'kinase inhibitors.' It blocks the action of an abnormal protein (the mesenchymal-epithelial transition [MET] gene) that helps cancer cells in the lungs grow and multiply. In this way, Rahika 150 mg Tablet slows or stops the growth and spread of cancer cells throughout the body.

How Rahika 150 mg Tablet Works

Rahika 150 mg Tablet contains 'Capmatinib,' which belongs to a class of medications called 'kinase inhibitors.' It works by blocking the action of an abnormal protein (the mesenchymal-epithelial transition [MET] gene) that helps cancer cells in the lungs grow and multiply, thereby preventing the cancer from spreading.

Storage

• Store in a cool and dry place away from sunlight.
• Keep it out of sight and reach of children.
• Non cold chain - To be stored in cool places at 10ÂºC to 25ÂºC or below 30ÂºC.

What if I have taken an overdose of Rahika 150 mg Tablet

Take Rahika 150 mg Tablet only as prescribed by your physician. Do not exceed the recommended dose, as it may result in an overdose. If you suspect you have taken an overdose or notice any unusual symptoms, seek immediate medical help from your doctor or a nearby hospital.

Drug Warnings

Before starting treatment with Rahika 150 mg Tablet , inform your doctor if you are allergic to any of its ingredients or other medications. Rahika 150 mg Tablet may increase your sensitivity to sunlight, so it is important to limit exposure to sunlight and use sunscreen and protective clothing when going outdoors. Do not use Rahika 150 mg Tablet if you are pregnant or planning pregnancy, as it may harm an unborn baby. Be sure to use effective birth control during treatment and for at least one month after your last dose. Tell your doctor about your medical history, particularly if you have liver disease, lung problems, or pancreatitis (inflammation of the pancreas), before starting Rahika 150 mg Tablet .

Diet & Lifestyle Advise

Do not smoke and limit exposure to secondhand smoke.
Avoid exposure to harmful substances at home or work, like radon, asbestos, and chemicals, to lower your chances of getting lung cancer.
Take into account your family history and HIV status; if you have a family history of lung cancer or are HIV-positive, talk to your doctor about the appropriate screenings for you.
If you are a heavy smoker, avoid taking beta-carotene supplements, as they might increase the risk of lung cancer.
Exercise regularly to stay healthy.
Consume a diet rich in fresh fruits and vegetables.
Keep up with the latest information about lung cancer and talk to your doctor about any personal risk factors or lifestyle changes that could help lower your risk.

Habit Forming

Therapeutic Class

ANTINEOPLASTIC

Alcohol

Consult your doctor

There is limited information on how alcohol consumption affects Rahika 150 mg Tablet . Please discuss with your doctor if you have concerns.

Pregnancy

Unsafe

Rahika 150 mg Tablet is not recommended for use during pregnancy, as it may harm an unborn baby. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Rahika 150 mg Tablet .

Breast Feeding

Unsafe

Rahika 150 mg Tablet should not be taken by breastfeeding mothers, as it passes into breast milk and may pose a potential risk to the infant

Driving

Caution

It is not known if Rahika 150 mg Tablet affects your driving ability. Drive only if you are fully alert and physically stable.

Liver

Caution

Rahika 150 mg Tablet should be used with caution in patients with liver impairment/disease.

Kidney

Caution

If prescribed by a doctor, Rahika 150 mg Tablet is safe for patients with mild kidney disease. However, it should be used with caution in patients with severe kidney disease, as there are limited studies on this group.

Children

Consult your doctor

There is no information on the safety of Rahika 150 mg Tablet in children below 12 years. If you have any concerns regarding the use of Rahika 150 mg Tablet for children, please consult a doctor.

Have a query?

FAQs

What is the use of Rahika 150 mg Tablet ?

Rahika 150 mg Tablet is a targeted cancer medicine used to treat advanced or non-small cell lung cancer that has spread to nearby tissues or other parts of the body.

How does Rahika 150 mg Tablet work?

Rahika 150 mg Tablet contains "Capmatinib," which belongs to a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein (the mesenchymal-epithelial transition [MET] gene) that helps cancer cells in the lungs grow and multiply, thereby preventing cancer from spreading.

What are the side effects of Rahika 150 mg Tablet ?

Common side effects of Rahika 150 mg Tablet include nausea, vomiting, coughing, difficulty breathing, fatigue, weakness, loss of appetite, muscle or bone pain, swelling in the hands or feet, or changes in certain blood tests. Most of these side effects are temporary and do not need medical attention. However, if these side effects persist or worsen, please consult your doctor.

Can Rahika 150 mg Tablet be given to children?

There is limited information on the safety and effectiveness of Rahika 150 mg Tablet in children. Therefore, consult your doctor if you have any concerns regarding its use for this age group.

Is Rahika 150 mg Tablet safe for pregnant women?

No, Rahika 150 mg Tablet is not recommended for pregnant women or those planning pregnancy, as it may harm an unborn baby. If you have any concerns, it is advisable to consult your doctor.

When can I plan a pregnancy if I am taking Rahika 150 mg Tablet ?

Since Rahika 150 mg Tablet may harm an unborn baby, it is not recommended to become pregnant during treatment with Rahika 150 mg Tablet . Use effective birth control while taking Rahika 150 mg Tablet and for at least one month after your final dose. If you plan to become pregnant, consult your doctor for further guidance.

How long can I take Rahika 150 mg Tablet ?

You should take Rahika 150 mg Tablet for as long as your doctor has prescribed it, based on your medical condition. However, if you experience any problems while taking Rahika 150 mg Tablet , please consult your doctor.

Country of origin

India

Manufacturer/Marketer address

Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Other Info - RAH0008

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Welcome User

Rahika 150 mg Tablet 12's

Know Your Delivery Time

Secure Payment

India's Most Trusted Pharmacy

Genuine Products

Composition :

Manufacturer/Marketer :

Consume Type :

Return Policy :

Expires on or after :

FAQs

What is the use of Rahika 150 mg Tablet ?

How does Rahika 150 mg Tablet work?

What are the side effects of Rahika 150 mg Tablet ?

Can Rahika 150 mg Tablet be given to children?

Is Rahika 150 mg Tablet safe for pregnant women?

When can I plan a pregnancy if I am taking Rahika 150 mg Tablet ?

How long can I take Rahika 150 mg Tablet ?

Disclaimer

Reference